<DOC>
	<DOCNO>NCT01775735</DOCNO>
	<brief_summary>The primary objective study evaluate safety efficacy occipital nerve stimulation ( ONS ) use Boston Scientific Corporation ( BSC ) Precision™ System management intractable chronic migraine , use conjunction anti-migraine medication .</brief_summary>
	<brief_title>Occipital Nerve Stimulation ( ONS ) Migraine : OPTIMISE</brief_title>
	<detailed_description>Initial report manage migraine headache ONS describe technique electrical lead implant subcutaneous space transverse occipital nerve , back head , x-ray guidance . The lead tunnel skin implantable pulse generator ( IPG ) implant chest wall abdomen . The OPTIMISE Trial design pivotal study Boston Scientific PRECISION neurostimulation system , system use ONS . The PRECISION System previously approve Spinal Cord Stimulation ( SCS ) .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Key Onset chronic migraine least 6 month prior start Screening determine welldocumented history Evidence intractability Posteriordominant head pain Stable pattern headache symptom least 6 month prior begin Screening Onset migraine age 50 If female childbearing potential : pregnant , evidence negative pregnancy test Key Diagnosed major psychiatric disorder specifically list Key Exclusion Criteria 24 ( e.g . multiple personality disorder , schizophrenia ) Untreated panic disorder Untreated major depression evidence PHQ9 score &gt; 20 Untreated generalized anxiety disorder evidence GAD7 score ≥15 Currently diagnose severe personality disorder A female childbearing potential planning get pregnant course study use adequate contraception Participating another drug , device , biologics trial within 3 month prior Screening A terminal illness associate survival &lt; 24 month</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>headache</keyword>
	<keyword>pain</keyword>
	<keyword>chronic</keyword>
</DOC>